On December 16th, Novo Nordisk announced plans to invest 8.5 billion Danish kroner to establish a new production base in Odense, Denmark. This investment marks the first time in this century that Novo Nordisk has established a new production base in Denmark. The construction project has begun and is scheduled to be completed by 2027. After the completion of the facility, this investment is expected to create 400 long-term jobs.